XML 114 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders' Equity - Data relating to grants of restricted stock (Details) - Restricted Stock
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at January 1, 2022 | shares 651,846
Granted | shares 151,080
Vested | shares (171,500)
Forfeited | shares (15,559)
Outstanding at December 31, 2022 | shares 615,867
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Average grant date fair value, Outstanding, Beginning balance | $ / shares $ 106.59
Average grant date fair value, Granted | $ / shares 133.94
Average grant date fair value, Vested | $ / shares 111.11
Average grant date fair value, Forfeited | $ / shares 109.33
Average grant date fair value, Outstanding, Ending balance | $ / shares $ 111.97